Home / Drug shortages / Rocuronium Bromide Injection

Rocuronium Bromide Injection — FDA Drug Shortage

Current — Hikma Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Rocuronium Bromide Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on 02/15/2023.

Shortage Details

Status
Current
Company
Hikma Pharmaceuticals USA, Inc.
Package NDC
0143-9251-10
Dosage Form
Injection
Presentation
Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9251-10)
Initial Posting
02/15/2023
Revised Date

FDA data resources